Lymphoma

Explore the newest discoveries and latest clinical insights on lymphoma. Cancer Nursing Today provides the most current perspectives and data on predictive models for the prognosis of patients with diffuse large B-cell lymphoma, toxicities in triplet therapies, CAR T-cell therapies, and more. Explore the latest clinical trial data, conference coverage, and breaking news on lymphoma.

FDA Announces Changes to PI3Ki Accelerated Approval Process
Phosphatidylinositol 3-kinase inhibitors (PI3Ki) are a class of drugs used to treat a specific type of breast cancer, known as hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA-mutated advanced breast cancer. However, some PI3Kis have been given US Food and Drug Administration (FDA) accelerated approval for the treatment of relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL). ...
Advertisement
Advertisement

Knowledge Hub

Breast Cancer
Breast Cancer

Trending

Advertisement
Advertisement
Latest News